신경조절(뉴로모듈레이션) 시장(2026-2030년)

The global neuromodulation market is forecasted to grow by USD 8855.5 mn during 2025-2030, accelerating at a CAGR of 14.0% during the forecast period. The report on the global neuromodulation market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of chronic pain and neurological disorders, global aging population fueling neuromodulation demand, emerging markets expanding due to healthcare infrastructure.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global neuromodulation market is segmented as below:

By Product

• Implantable neuromodulation devices
• External neuromodulation devices

By End-User

• Hospitals
• ASCs
• Others

By Application

• Epilepsy
• Obesity
• Depression
• Ischemia

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • The Netherlands
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the non-invasive and wearable devices enabling home therapy as one of the prime reasons driving the global neuromodulation market growth during the next few years. Also, digital therapeutics integration improving adherence and tracking and miniaturized mri-safe implants enhancing patient comfort will lead to sizable demand in the market.

The report on the global neuromodulation market covers the following areas:

• Global neuromodulation market sizing
• Global neuromodulation market forecast
• Global neuromodulation market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global neuromodulation market vendors that include Abbott Laboratories, BioWave Ltd., Boston Scientific Corp., BrainsWay Ltd., Cognito Therapeutics Inc., electroCore Inc., Flow Neuroscience AB, INSIGHTEC Ltd., LivaNova PLC, Medtronic Plc, Neuroelectrics Barcelona SLU, Neuronetics Inc., NeuroPace Inc., NeuroSigma Inc., Nevro Corp., Saluda Medical Pty Ltd., Synapse Biomedical Inc., Theranica Bio Electronics Ltd.. Also, the global neuromodulation market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Product
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Neuromodulation Market 2020 - 2024
  • Historic Market Size - Data Table on Global Neuromodulation Market 2020 - 2024 ($ million)
• 5.2 Product segment analysis 2020 - 2024
  • Historic Market Size - Product Segment 2020 - 2024 ($ million)
• 5.3 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
• 5.4 Application segment analysis 2020 - 2024
  • Historic Market Size - Application Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 The Impact of AI on Global Neuromodulation Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Product

• 8.1 Market segments
• 8.2 Comparison by Product
• 8.3 Implantable neuromodulation devices - Market size and forecast 2025-2030
• 8.4 External neuromodulation devices - Market size and forecast 2025-2030
• 8.5 Market opportunity by Product
  • Market opportunity by Product ($ million)

9 Market Segmentation by End-user

• 9.1 Market segments
• 9.2 Comparison by End-user
• 9.3 Hospitals - Market size and forecast 2025-2030
• 9.4 ASCs - Market size and forecast 2025-2030
• 9.5 Others - Market size and forecast 2025-2030
• 9.6 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

10 Market Segmentation by Application

• 10.1 Market segments
• 10.2 Comparison by Application
• 10.3 Epilepsy - Market size and forecast 2025-2030
• 10.4 Obesity - Market size and forecast 2025-2030
• 10.5 Depression - Market size and forecast 2025-2030
• 10.6 Ischemia - Market size and forecast 2025-2030
• 10.7 Market opportunity by Application
  • Market opportunity by Application ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 France - Market size and forecast 2025-2030
  • 12.4.3 UK - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 Spain - Market size and forecast 2025-2030
  • 12.4.6 The Netherlands - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 Japan - Market size and forecast 2025-2030
  • 12.5.3 India - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Indonesia - Market size and forecast 2025-2030
  • 12.5.6 Thailand - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.3 UAE - Market size and forecast 2025-2030
  • 12.6.4 Turkey - Market size and forecast 2025-2030
  • 12.6.5 Argentina - Market size and forecast 2025-2030
  • 12.6.6 Colombia - Market size and forecast 2025-2030
  • 12.6.7 South Africa - Market size and forecast 2025-2030
  • 12.6.8 Israel - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Rising prevalence of chronic pain and neurological disorders
  • Global aging population fueling neuromodulation demand
  • Emerging markets expanding due to healthcare infrastructure
• 13.2 Market challenges
  • High device and procedure costs limiting accessibility
  • Stringent regulatory approvals delaying market entry
  • Supply-chain inefficiencies increasing delays and costs
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Non-invasive and wearable devices enabling home therapy
  • Digital therapeutics integration improving adherence and tracking
  • Miniaturized MRI-safe implants enhancing patient comfort

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Abbott Laboratories
  • Abbott Laboratories - Overview
  • Abbott Laboratories - Business segments
  • Abbott Laboratories - Key news
  • Abbott Laboratories - Key offerings
  • Abbott Laboratories - Segment focus
  • SWOT
• 15.5 Boston Scientific Corp.
  • Boston Scientific Corp. - Overview
  • Boston Scientific Corp. - Business segments
  • Boston Scientific Corp. - Key news
  • Boston Scientific Corp. - Key offerings
  • Boston Scientific Corp. - Segment focus
  • SWOT
• 15.6 BrainsWay Ltd.
  • BrainsWay Ltd. - Overview
  • BrainsWay Ltd. - Product / Service
  • BrainsWay Ltd. - Key offerings
  • SWOT
• 15.7 Cognito Therapeutics Inc.
  • Cognito Therapeutics Inc. - Overview
  • Cognito Therapeutics Inc. - Product / Service
  • Cognito Therapeutics Inc. - Key offerings
  • SWOT
• 15.8 electroCore Inc.
  • electroCore Inc. - Overview
  • electroCore Inc. - Product / Service
  • electroCore Inc. - Key offerings
  • SWOT
• 15.9 Flow Neuroscience AB
  • Flow Neuroscience AB - Overview
  • Flow Neuroscience AB - Product / Service
  • Flow Neuroscience AB - Key offerings
  • SWOT
• 15.10 INSIGHTEC Ltd.
  • INSIGHTEC Ltd. - Overview
  • INSIGHTEC Ltd. - Product / Service
  • INSIGHTEC Ltd. - Key offerings
  • SWOT
• 15.11 LivaNova PLC
  • LivaNova PLC - Overview
  • LivaNova PLC - Business segments
  • LivaNova PLC - Key news
  • LivaNova PLC - Key offerings
  • LivaNova PLC - Segment focus
  • SWOT
• 15.12 Medtronic Plc
  • Medtronic Plc - Overview
  • Medtronic Plc - Business segments
  • Medtronic Plc - Key news
  • Medtronic Plc - Key offerings
  • Medtronic Plc - Segment focus
  • SWOT
• 15.13 Neuronetics Inc.
  • Neuronetics Inc. - Overview
  • Neuronetics Inc. - Product / Service
  • Neuronetics Inc. - Key offerings
  • SWOT
• 15.14 NeuroPace Inc.
  • NeuroPace Inc. - Overview
  • NeuroPace Inc. - Product / Service
  • NeuroPace Inc. - Key offerings
  • SWOT
• 15.15 NeuroSigma Inc.
  • NeuroSigma Inc. - Overview
  • NeuroSigma Inc. - Product / Service
  • NeuroSigma Inc. - Key offerings
  • SWOT
• 15.16 Nevro Corp.
  • Nevro Corp. - Overview
  • Nevro Corp. - Product / Service
  • Nevro Corp. - Key offerings
  • SWOT
• 15.17 Saluda Medical Pty Ltd.
  • Saluda Medical Pty Ltd. - Overview
  • Saluda Medical Pty Ltd. - Product / Service
  • Saluda Medical Pty Ltd. - Key offerings
  • SWOT
• 15.18 Theranica Bio Electronics Ltd.
  • Theranica Bio Electronics Ltd. - Overview
  • Theranica Bio Electronics Ltd. - Product / Service
  • Theranica Bio Electronics Ltd. - Key offerings
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations